Tag: McKesson Medical-Surgical
Wellverse promises investments, continuity for HME providers
October 2, 2026Liz Beaulieu, Editor
IRVING, Texas – Wellverse will use its independence to accelerate investments in distribution and private-label products, while maintaining its longstanding commitment to HME providers, says President Stanton McComb.
Here's what McComb had to say about what will be changing and, equally as important, what won't be changing as the company makes its official name change from McKesson Medical-Surgical Solutions to Wellverse in the new year.
Independence fuels investment
Wellverse...
McKesson signals next phase for MMS with new name
August 7, 2026Liz Beaulieu, Editor
IRVING, Texas – McKesson’s Medical-Surgical Solutions business plans to formally operate as Wellverse starting in January 2027, as part of a phased transition, says McKesson CEO Brian Tyler.
The company announced the new name on Aug. 5 as part of its financial results for the first quarter of fiscal year 2027.
“Wellverse delivers a future where health care providers and patients thrive,” Tyler said during a conference call to discuss the results. “This is an important...
McKesson debuts Wellverse name for Medical-Surgical Solutions business
August 6, 2026HME News Staff
IRVING, Texas – McKesson has announced Wellverse is the new name of the future standalone McKesson Medical-Surgical Solutions business.
As part of its fiscal year 2027 first quarter financial results, the company also noted that on June 9 it established a secured Term Loan B facility of $2.25 billion in support of the planned separation of the business. Previously, it sold an approximately 13% minority interest in the business to Apollo Funds for $1.25 billion.
“This represents...
McKesson moves MMS closer to IPO
May 15, 2026Liz Beaulieu, Editor
IRVING, Texas – McKesson’s Medical-Surgical Solutions (MMS) segment is now operationally and legally separate, and with new financing and a new minority ownership, it is closer to becoming financially independent, says CFO Britt Vitalone.
In early April, the company announced:
A $1 billion revolving credit facility and the issuance of $1 billion in Term Loan A facilities.
The sale of a 13% minority interest to funds managed by Apollo in a deal that values the segment at $13...
McKesson says it is well-positioned going into 2027
May 11, 2026HME News Staff
IRVING, Texas – McKesson Corp. has reported consolidated revenues of $96.3 billion for the fourth quarter of fiscal year 2026, a 6% increase. It reported revenues of $403.4 billion for the full year, a 12% increase.
Fourth quarter highlights:
Earnings per diluted share of $13.71 increased $3.70.
Adjusted Earnings per diluted share of $11.69 increased 16%.
McKesson entered into a $2.25 billion accelerated share repurchase program.
McKesson’s board of directors approved a...
McKesson sells stake in Medical-Surgical Solutions
April 29, 2026HME News Staff
IRVING, Texas – McKesson has taken another step toward separating its Medical-Surgical Solutions (MMS) business by selling a minority interest to funds managed by Apollo.
Apollo Funds will invest $1.25 billion in convertible preferred equity of MMS to acquire an approximately 13% minority interest, valuing the business at approximately $13 billion.
“This transaction marks a key milestone in McKesson’s planned separation of MMS,” said Brian Tyler, CEO of McKesson. “We...
McKesson reports flat revenues for Medical-Surgical segment
February 9, 2026HME News Staff
IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty pharmaceuticals.
For the segment, operating profit was $265 million, and adjusted segment operating profit was $265 million, a 10% decrease, driven by lower volumes across physician office settings and lower incidence of illness for the season.
McKesson reported $106.2...
McKesson fully exits European market
February 3, 2026HME News Staff
IRVING, Texas – McKesson has announced that it has sold its retail and distribution businesses in Norway to NorgesGruppen, a privately-owned retail group. McKesson previously announced that it planned to divest Norway, which is included in its Other segment. The transaction represents the final step in the company’s commitment to fully exit its European operations. The move allows the company to focus strategy and capital allocation on expanding...
McKesson leverages portfolio discipline in latest spin-off strategy
September 26, 2025Liz Beaulieu, Editor
IRVING, Texas – McKesson is moving forward with a planned spin-off of its Medical-Surgical Solutions business, aiming to bring both organizations into “sharper focus.” The separation is designed to streamline operations, unlock growth opportunities, and enhance strategic execution across McKesson’s core platforms, company officials said at an Investor Day on Sept. 23.
Medical-Surgical Solutions provides supply distribution, logistics and related services to health...
McKesson to spin off Medical-Surgical Solutions segment, focus on high-growth oncology and biopharma markets
June 3, 2025HME News Staff
IRVING, Texas – McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company.
This strategic move is aimed at sharpening McKesson’s focus on higher-growth, higher-margin opportunities in Oncology and Biopharma Solutions, aligning with its long-term enterprise strategy.
“Disciplined capital deployment and portfolio management are hallmarks of our strategy,” said Brian Tyler, CEO of McKesson. “This separation...